Profusa (PFSA) Cash & Current Investments (2021 - 2026)
Profusa's (PFSA) quarterly Cash & Current Investments came in at $375000.0 in Q1 2026, up 1932.52% year-on-year from $18450.0 in Q1 2025, and down 78.91% quarter-over-quarter from $1.8 million in Q4 2025.
Profusa (PFSA) Cash & Current Investments (2021 - 2026) Analysis & Trends
Profusa's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $375000.0 for Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 1932.52% year-over-year to $375000.0 in Q1 2026; TTM through Mar 2026 was $375000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.8 million, up 830.89% from the prior year.
- Cash & Current Investments fell to $375000.0 in Q1 2026 per PFSA's latest filing, from $1.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $3.0 million in Q3 2025 and bottomed at $533.0 in Q3 2024.
- The 5-year median for Cash & Current Investments is $193486.0 (2022), against an average of $439139.1.
- Across the five-year window, Cash & Current Investments slumped 97.87% in 2024 and jumped 564440.34% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $193486.0 in 2022, then slumped by 97.66% to $4519.0 in 2023, then soared by 4126.6% to $191000.0 in 2024, then soared by 830.89% to $1.8 million in 2025, then sank by 78.91% to $375000.0 in 2026.
- Per Business Quant, the three latest PFSA Cash & Current Investments figures stand at $375000.0 (Q1 2026), $1.8 million (Q4 2025), and $3.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.12 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 577.00 Mn |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | 375,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 375,000.00 |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 1,751.00 |
| Mar 31, 2025 | 18,450.00 |
| Dec 31, 2024 | 191,000.00 |
| Sep 30, 2024 | 533.00 |
| Jun 30, 2024 | 6,496.00 |
| Mar 31, 2024 | 5,314.00 |
| Dec 31, 2023 | 4,519.00 |
| Sep 30, 2023 | 17,342.00 |
| Jun 30, 2023 | 250,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | 193,486.00 |
| Sep 30, 2022 | 372,871.00 |
| Jun 30, 2022 | 480,726.00 |
| Mar 31, 2022 | 510,876.00 |
| Dec 31, 2021 | 741,228.00 |